Effectiveness of Naltrexone and/or Ondansetron to Reduce Craving for Alcohol and Drinking
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether naltrexone (an opiate blocking agent
approved for the treatment of alcohol dependence), ondansetron a serotonin 3 antagonist
medication approved to treat nausea) or their combination are effective in the reduction of
alcohol craving and drinking compared to placebo.
Phase:
Phase 2
Details
Lead Sponsor:
Medical University of South Carolina
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)